Your browser doesn't support javascript.
Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark.
Michaelsen, Thomas Y; Bennedbæk, Marc; Christiansen, Lasse E; Jørgensen, Mia S F; Møller, Camilla H; Sørensen, Emil A; Knutsson, Simon; Brandt, Jakob; Jensen, Thomas B N; Chiche-Lapierre, Clarisse; Collados, Emilio F; Sørensen, Trine; Petersen, Celine; Le-Quy, Vang; Sereika, Mantas; Hansen, Frederik T; Rasmussen, Morten; Fonager, Jannik; Karst, Søren M; Marvig, Rasmus L; Stegger, Marc; Sieber, Raphael N; Skov, Robert; Legarth, Rebecca; Krause, Tyra G; Fomsgaard, Anders; Albertsen, Mads.
  • Michaelsen TY; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Bennedbæk M; Centre of Excellence for Health, Immunity and Infection (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Christiansen LE; Department of Applied Mathematics and Computer Science, Technical University of Denmark, Lyngby, Denmark.
  • Jørgensen MSF; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Møller CH; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Sørensen EA; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Knutsson S; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Brandt J; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Jensen TBN; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Chiche-Lapierre C; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Collados EF; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Sørensen T; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Petersen C; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Le-Quy V; Unit for Research Data Services (CLAAUDIA), Aalborg University, Aalborg, Denmark.
  • Sereika M; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Hansen FT; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark.
  • Rasmussen M; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Fonager J; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Karst SM; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Marvig RL; Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Stegger M; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Sieber RN; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Skov R; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Legarth R; Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Krause TG; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Fomsgaard A; Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Albertsen M; Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark. ma@bio.aau.dk.
Genome Med ; 14(1): 47, 2022 05 04.
Article in English | MEDLINE | ID: covidwho-1910346
ABSTRACT

BACKGROUND:

In early 2021, the SARS-CoV-2 lineage B.1.1.7 (Alpha variant) became dominant across large parts of the world. In Denmark, comprehensive and real-time test, contact-tracing, and sequencing efforts were applied to sustain epidemic control. Here, we use these data to investigate the transmissibility, introduction, and onward transmission of B.1.1.7 in Denmark.

METHODS:

We analyzed a comprehensive set of 60,178 SARS-CoV-2 genomes generated from high-throughput sequencing by the Danish COVID-19 Genome Consortium, representing 34% of all positive cases in the period 14 November 2020 to 7 February 2021. We calculated the transmissibility of B.1.1.7 relative to other lineages using Poisson regression. Including all 1976 high-quality B.1.1.7 genomes collected in the study period, we constructed a time-scaled phylogeny, which was coupled with detailed travel history and register data to outline the introduction and onward transmission of B.1.1.7 in Denmark.

RESULTS:

In a period with unchanged restrictions, we estimated an increased B.1.1.7 transmissibility of 58% (95% CI [56%, 60%]) relative to other lineages. Epidemiological and phylogenetic analyses revealed that 37% of B.1.1.7 cases were related to the initial introduction in November 2020. The relative number of cases directly linked to introductions varied between 10 and 50% throughout the study period.

CONCLUSIONS:

Our findings corroborate early estimates of increased transmissibility of B.1.1.7. Both substantial early expansion when B.1.1.7 was still unmonitored and continuous foreign introductions contributed considerably to case numbers. Finally, our study highlights the benefit of balanced travel restrictions and self-isolation procedures coupled with comprehensive surveillance efforts, to sustain epidemic control in the face of emerging variants.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: Genome Med Year: 2022 Document Type: Article Affiliation country: S13073-022-01045-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: Genome Med Year: 2022 Document Type: Article Affiliation country: S13073-022-01045-7